• Australian Pharmacist - Bowel Cancer Screening (Education Extra, August 2010)
  Screening to decrease the incidence of bowel cancer is possible as there is an identifiable precursor lesion in the form of an adenomatous polyp which is easily amenable to local therapy.  Forty per cent (40%) reductions in bowel cancer mortality resulting from those who actually performed the test has been reported.

• BowelScreen Australia^TM  
  BowelScreen Australia^TM is a pharmacy-based awareness, education and screening program.  It is a collaboration between Bowel Cancer Australia and the Pharmacy Guild of Australia, with support from Enterix Australia.  Education resouces are available for Pharmacists and Pharmacy staff on the Program's website.

• MedicineToday - Screening for Colorectal Cancer (May 2010)
  With access to one of the few population-based colorectal cancer screening programs in the world, Australian patients have the opportunity to have bowel cancer prevention incorporated into their health maintenance plans.  Screening asymptomatic people can detect cancers at an earlier, and therefore more curable, stage, resulting in a reduction in mortality.

• EdCaN resources for cancer nurses and allied health case study regarding colorectal cancers
  Cancer Australia.  The resources are designed to support the professional development of all nurses in cancer care regardless of experience or setting. They provide highly flexible and accessible education materials to help: all nurses achieve the core capabilities required in cancer control specialist cancer nurses benchmark against the specialist cancer nurse competency standards educators facilitate learning for all nurses in cancer control.

• The It’s Crunch Time™ campaign was an initiative of the Bowel Cancer Australia promoting participation by eligible Australians in the National Bowel Cancer Screening Program.

GP summary

Specialist mouse pad

Specialist summary

• MedicineToday - Colorectal Cancer Screening (June 2007)  
  Targeted population screening can help prevent colorectal cancer.  Diagnosis of asymptomatic colorectal cancer and polypectomy to prevent cancer development are the goals of screening.

• Clinical Practice Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer (2005)  
  National Health & Medical Research Council  (NHMRC).  This document is an update of the 1999 NHMRC document 'Guidelines for the prevention, early detection and management of colorectal cancer' and has been developed by the Australian Cancer Network.  The guidelines are intended for use by medical practitioners and health workers and provide information on prevention and screening, diagnosis and psychosocial matters, as well as the clinical aspects of surgery, radiotherapy and chemotherapy.

• Clinical Practice Guidelines Familial Aspects of Cancer: a Guide to Clinical Practice (1999)  
  National Health & Medical Research Council  (NHMRC).  Family history is widely recognised as an important risk factor for common cancer, and 5-10 percent of cancers are considered to be attributable to an inherited cancer predisposition.  During the past decade there have been major developments in cancer genetics with the identification and characterisation of genes involved in the inherited forms of several common human cancers.  The improved ability to detect individuals at high risk though analysis of their family history and/or genetic testing has been accompanied by major advances in screening, surveillance and prevention.